Lifeboat Foundation: Safeguarding Humanity
Toggle light / dark theme

Blog – Page 8983

From interpreting CT scans to diagnosing eye disease, artificial intelligence is taking on medical tasks once reserved for only highly trained medical specialists — and in many cases outperforming its human counterparts.

Now AI is starting to show up in intensive care units, where hospitals treat their sickest patients. Doctors who have used the new systems say AI may be better at responding to the vast trove of medical data collected from ICU patients — and may help save patients who are teetering between life and death.

Read more | >

Patients are about to be enrolled in the first study to test a gene-editing technique known as CRISPR inside the body to try to cure an inherited form of blindness.

People with the disease have normal eyes but lack a gene that converts light into signals to the brain that enable sight.

The experimental treatment aims to supply kids and adults with a healthy version of the gene they lack, using a tool that cuts or “edits” DNA in a specific spot. It’s intended as a onetime treatment that permanently alters the person’s native DNA.

Read more | >

Research on robotic prostheses is coming along in leaps and bounds, but one hurdle is proving quite tricky to overcome: a sense of touch. Among other things, this sense helps us control our grip strength — which is vitally important when it comes to having fine motor control for handling delicate objects.

Enter a new upgrade for the LUKE Arm — named for Luke Skywalker, the Star Wars hero with a robotic hand. Prototype versions of this robotic prosthesis can be linked up to the wearer’s nerves.

And, thanks to biomedical engineers at the University of Utah, for the participants of their experimental study, the arm can now also produce an ability to feel. This spectacular advance allowed one wearer to handle grapes, peel a banana, and even feel his wife’s hand in his.

Read more | >

New research from the USC Viterbi School of Engineering could be key to our understanding of how the aging process works. The findings potentially pave the way for better cancer treatments and revolutionary new drugs that could vastly improve human health in the twilight years.

The work, from Assistant Professor of Chemical Engineering and Materials Science Nick Graham and his team in collaboration with Scott Fraser, Provost Professor of Biological Sciences and Biomedical Engineering, and Pin Wang, Zohrab A. Kaprielian Fellow in Engineering, was recently published in the Journal of Biological Chemistry.

“To drink from the fountain of youth, you have to figure out where the fountain of youth is, and understand what the fountain of youth is doing,” Graham said. “We’re doing the opposite; we’re trying to study the reasons cells age, so that we might be able to design treatments for better aging.”

Read more | >

Sometimes the best discoveries happen when scientists least expect it. While trying to replicate another team’s finding, Stanford physicists recently stumbled upon a novel form of magnetism, predicted but never seen before, that is generated when two honeycomb-shaped lattices of carbon are carefully stacked and rotated to a special angle.

The authors suggest the magnetism, called orbital ferromagnetism, could prove useful for certain applications, such as quantum computing. The group describes their finding in the July 25 issue of the journal Science.

“We were not aiming for magnetism. We found what may be the most exciting thing in my career to date through partially targeted and partially accidental exploration,” said study leader David Goldhaber-Gordon, a professor of physics at Stanford’s School of Humanities and Sciences. “Our discovery shows that the most interesting things turn out to be surprises sometimes.”

Read more | >

Central London’s freshwater sources contain high levels of antibiotic resistant genes, with the River Thames having the highest amount, according to research by UCL.

The Regent’s Canal, Regent’s Park Pond and the Serpentine all contained the genes but at lower levels than the Thames, which contained genes providing resistance for bacteria to such as penicillin, erythromycin and tetracycline.

The genes come from bacteria in human and animal waste. When antibiotics are taken by humans much of the drug is excreted into the and then into freshwater sources. The presence of antibiotics in these sources provides an environment where microbes carrying the resistance genes can multiply quicker and share their resistance with other microbes.

Read more | >